Dermatomyositis laboratory findings

Dermatomyositis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Dermatomyositis from other Diseases
Epidemiology and Demographics
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
X Ray
MRI
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Dermatomyositis laboratory findings On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Dermatomyositis laboratory findings All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Dermatomyositis laboratory findings
CDC on Dermatomyositis laboratory findings
Dermatomyositis laboratory findings in the news
Blogs on Dermatomyositis laboratory findings
Directions to Hospitals Treating Dermatomyositis
Risk calculators and risk factors for Dermatomyositis laboratory findings

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Creatine kinase (CK) and aldolase levels may be increased, which would be indicative of muscle damage.

Laboratory Findings

Blood tests such as creatine kinase (CK) and aldolase may help diagnose dematomyositis. Patients with dematomyositis may show increased CK and aldolase levels, indicating muscle damage.